Nyxoah Sa (NYXH)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1111)

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
NYXH Nyxoah Sa	3.85	172.03M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	492.22	177.98B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	168.56	48.78B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	82.16	41.08B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	251.84	37.74B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	43.88	34.80B	28.43B	1.16B	1.26B	1.4457

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2023-07-31	開始されました	H.C. Wainwright	Buy
2023-07-19	開始されました	Robert W. Baird	Neutral
2022-04-21	開始されました	Oppenheimer	Outperform
2022-04-06	開始されました	Wolfe Research	Peer Perform
2021-12-21	再開されました	Cantor Fitzgerald	Overweight
2021-07-28	開始されました	Cantor Fitzgerald	Overweight

Nyxoah Sa (NYXH) 最新ニュース

Nyxoah Sa (NYXH) 財務データ

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, ALC, RMD, MDLN

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa (NYXH) 最新ニュース

Cantor Fitzgerald Upgrades Nyxoah (NASDAQ:NYXH) to "Strong-Buy" - MarketBeat

Nyxoah SA (NASDAQ:NYXH) Short Interest Down 17.8% in February - MarketBeat

Portfolio Recap: Will Nyxoah SA benefit from rising consumer demandProfit Target & Risk Controlled Daily Plans - baoquankhu1.vn

Publication relating to transparency notifications - GlobeNewswire

Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com

Nyxoah SA (NYXH) Stock Analysis: Exploring a 149% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Information on the total number of voting rights and shares - GlobeNewswire

EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn

Macro Review: Can Nyxoah SA expand into new marketsJuly 2025 Update & High Accuracy Investment Signals - baoquankhu1.vn

What’s Nyxoah SA’s historical returnQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru

EV Market: Is Nyxoah SA forming bullish engulfing patternsIPO Watch & Weekly Chart Analysis and Guides - baoquankhu1.vn

Nyxoah SA (NYXH) Stock Analysis: Unveiling a 126% Potential Upside in Sleep Apnea Solutions - DirectorsTalk Interviews

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - Bitget

Nyxoah SA (NASDAQ:NYXH) Short Interest Up 29.0% in January - Defense World

(NYXH) Volatility Zones as Tactical Triggers - Stock Traders Daily

Contrasting Hinge Health (NYSE:HNGE) and Nyxoah (NASDAQ:NYXH) - Defense World

Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - MSN

Nyxoah SA (NASDAQ:NYXH) Short Interest Update - MarketBeat

NYXH Technical Analysis & Stock Price Forecast - Intellectia AI

Is Nyxoah SA stock undervalued right nowJuly 2025 Highlights & Weekly Stock Breakout Alerts - mfd.ru

Nyxoah SA (NYXH) Stock Analysis: A Healthcare Innovator with a Promising 138.98% Upside Potential - DirectorsTalk Interviews

Returns Recap: Will Nyxoah SA benefit from AI trendsWeekly Stock Recap & Community Supported Trade Ideas - baoquankhu1.vn

Is Nyxoah SA stock overvalued or fairly pricedJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru

Can Nyxoah SA expand into new marketsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - mfd.ru

What is the long term forecast for Nyxoah SA stockJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - mfd.ru

Nyxoah's Revenue On The Rise- Will The Stock Wake From Its Slumber? - RTTNews

Guidance Update: Is now the right time to enter Nyxoah SABond Market & Daily Stock Trend Watchlist - baoquankhu1.vn

Price-Driven Insight from (NYXH) for Rule-Based Strategy - Stock Traders Daily

Nyxoah SA (NYXH) Stock Analysis: A 137% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews

Aug PreEarnings: Can Nyxoah SA sustain its profitabilityBear Alert & Expert Approved Trade Ideas - baoquankhu1.vn

Price Action: Should I hold or sell Nyxoah SA now2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Ideas Watch: Is now the right time to enter Nyxoah SAQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn

Will Nyxoah SA benefit from rising consumer demandWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn

Nyxoah (NASDAQ:NYXH) Shares Down 0.4%Time to Sell? - MarketBeat

Nyxoah (NASDAQ:NYXH) Shares Down 0.4% – Time to Sell? - Defense World

Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy - The Globe and Mail

Risk Hedge: Is Nyxoah SA stock a good dividend stockTrade Ideas & Long-Term Growth Plans - mfd.ru

Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru

Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn

Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review

Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Nyxoah invests in further expanding its Belgian manufacturing capacity to support its worldwide growth - marketscreener.com

Nyxoah says co invests expanding its Belgian manufacturing capacity - marketscreener.com

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewswire

Does Nyxoah SA have pricing power2025 Risk Factors & Growth Focused Stock Reports - bollywoodhelpline.com

Aug Sectors: Is Flanigans Enterprises Inc stock a falling knife or bargain buy2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn

(NYXH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

NYXH: Rapid U.S. launch and strong clinical results position Genio for significant market growth - TradingView

NYXH: Genio's innovative sleep apnea device drives rapid U.S. adoption and strong early sales - TradingView — Track All Markets

Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛

Nyxoah’s First Full U.S. Sales Quarter Fuels Triple-Digit Revenue Growth in 2025 - The Globe and Mail

Nyxoah Sa (NYXH) 財務データ

収益

当期純利益

現金流量

EPS

NYXHに似た銘柄